Design and development of injectable intraperitoneal sustained release drug delivery system for ovarian cancer

Multiple clinical trials have shown improved survival after IP (intraperitoneal) over IV (intravenous) chemotherapy in women with optimally resected ovarian cancer and the National Cancer Institute (NCI) encourages the use of IP chemotherapy. Despite this, IP chemotherapy has still not been widely a...

Full description

Bibliographic Details
Main Author: Nazir, Chaudhry Zahid
Format: Thesis (University of Nottingham only)
Language:English
Published: 2020
Subjects:
Online Access:https://eprints.nottingham.ac.uk/60844/

Similar Items